I agree...A CEO for the U.S. in addition to a CEO for Europe and ROW, are now needed for Vascepa and other EPA drugs....I'm surprised this hasn't happened already. One CEO can not adequately do justice to the entire global market.
Question...Which individual at Amarin is presently responsible for the U.S. market?...I believe a BP would attend to this matter appropriately.
News 
Market Data 
Discover 
AI
